If you had an extra $800 million, would you buy the company?
$800 million is petty cash for Amgen.
REGN was once a cheap market cap stock with a robust pipeline. Today it is a Big Dog.
ARRY could be bought by any firm, at any time, if shareholders are paid a fair price.